NIH-funded research R01 grant

A long-acting vaginal ring to prevent genital herpes and pregnancy

Official title: A Novel, Multi-compartment Intravaginal Ring for Prevention of Genital Herpes and Unintended Pregnancy

Funded at Oak Crest Institute of Science · NIH-11361701 · Data updated 2026-11-12

A new vaginal ring that slowly releases antiviral and contraceptive ingredients to help prevent herpes and unintended pregnancy for women.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOak Crest Institute of Science
NIH-funded
Lab location1 site (Monrovia, United States)
Project startSeptember 10, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$815,431
NIH project number5R01AI175437-03
Project IDNIH-11361701 on NIH RePORTER

Who could benefit from this research

Could help

Women seeking long-acting, user-controlled protection against herpes, HPV, HIV, and pregnancy.

Less likely to help

Individuals seeking non-vaginal methods or those with contraindications to vaginal rings may not benefit.

What this research studies

This grant focuses on a next-generation intravaginal ring that could deliver an antiviral peptide along with sperm-suppressing agents over an extended period. The approach aims to simplify protection by combining prevention of herpes, HPV, HIV, and pregnancy in one user-controlled product. The research includes designing a multi-compartment ring and testing its delivery characteristics to ensure steady, long-term release. If successful, this could offer a convenient option for women to protect their sexual health without daily or pericoital dosing.

Why it matters

Potential benefit: If successful, it could provide a convenient, multipurpose protection method against sexually transmitted infections and unintended pregnancy.

How similar studies have gone: Previous work suggests multipurpose prevention technologies can improve uptake and adherence, but this exact two-drug, multi-compartment IVR is novel.

Where this research is happening

  • Oak Crest Institute of Science
    Monrovia, United States
    Active

Researchers

  • Principal investigator: Baum, Marc Michael — Oak Crest Institute of Science
  • Study coordinator: Baum, Marc Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.